Rapid Voluntary Licensing
Rapid voluntary licensing is used to bring technology to manufacturers and users as quickly as possible while respecting regulatory approvals.
Final
Checklist for Voluntary Licensing of Pharmaceutical Drugs
11 Good Practice Recommendations which draw on a record of successful deployments of VLs and as such are grounded in a substantial body of Customary Practice (CP).
Head License Executed Agreement MPP MSD
final
Amendement Head License MPP MSD July 2022final
Form of Sublicense Agreement - MOLfinal
Second Amended and Restated License Agreement - MPP and Gileadfinal
Amended and Restarted Voluntary HCV License Agreement - Gilead 2017final
Original HIV Voluntary License Agreement - Gilead 2006final
Final
Rapid Voluntary Licensing: A Good Practice guide for Medical Devices
Guidelines that are designed to highlight the main issues to be considered in a Rapid Voluntary License with particular emphasis on medical devices.